Irina V Kaplan

Medicine · Health Sciences

13h-index1.3kcitations30works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Rheumatoid Arthritis Research and Therapies(9), Systemic Lupus Erythematosus Research(7), Neuroscience and Neuropharmacology Research(5), Chronic Lymphocytic Leukemia Research(3), Nuclear Receptors and Signaling(3)

Publications30 total

Serum endocan levels in multiple sclerosis relapse and remission.
PubMed·2021· 6 cited
The role of training in effective simulated self-injection of subcutaneous depot medroxyprogesterone acetate: observations from a usability study
Contraception·2016· 8 cited
Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist
Seminars in Arthritis and Rheumatism·2016· 123 citedOpen Access
Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme
Annals of the Rheumatic Diseases·2015· 165 citedOpen Access
Potential Mechanisms Leading to the Abnormal Lipid Profile in Patients With Rheumatoid Arthritis Versus Healthy Volunteers and Reversal by Tofacitinib
Arthritis & Rheumatology·2014· 181 citedOpen Access
The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
Annals of the Rheumatic Diseases·2014· 287 citedOpen Access
THU0147 Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancies across the Rheumatoid Arthritis Clinical Programme
Annals of the Rheumatic Diseases·2014· 2 cited
Evaluation of the potential interaction between tofacitinib and drugs that undergo renal tubular secretion using metformin, an in vivo marker of renal organic cation transporter 2
Clinical Pharmacology in Drug Development·2014· 10 cited
Evaluation of the effect of fluconazole and ketoconazole on the pharmacokinetics of tofacitinib in healthy adult subjects
Clinical Pharmacology in Drug Development·2013· 46 cited
FRI0137 Effects of tofacitinib on lipid biomarkers in patients with active rheumatoid arthritis
Annals of the Rheumatic Diseases·2013· 7 cited
OP0253 The JAK Inhibitor Tofacitinib Suppresses Synovial JAK1-STAT1 Signalling in Rheumatoid Arthritis
Annals of the Rheumatic Diseases·2013· 4 cited
Abstract 124: Increased Selective Clearance of Cholesteryl-Ester in Patients with Rheumatoid Arthritis is Reversed by Treatment with Tofacitinib
Arteriosclerosis Thrombosis and Vascular Biology·2013
AB0160 Effects of TOFACITINIB (CP-690,550) on lipid biomarkers in rat adjuvant-induced arthritis (AIA) model and in patients with active rheumatoid arthritis
Annals of the Rheumatic Diseases·2012· 3 cited
THU0131 Tofacitinib (CP-690,550), an oral janus kinase inhibitor: Analysis of malignancies across the rheumatoid arthritis clinical programme
Annals of the Rheumatic Diseases·2012· 10 cited
146 – THE EFFICACY OF A LOCALLY INJECTABLE PROSTAGLANDIN EP-2 RECEPTOR AGONIST ON FRACTURE HEALING
2011
The efficacy of a locally injectable prostaglandin EP-2 receptor agonist on fracture healing
Bone·2010· 2 cited
Central Nervous System Pharmacokinetics of the Mdr1 P-Glycoprotein Substrate CP-615,003: Intersite Differences and Implications for Human Receptor Occupancy Projections from Cerebrospinal Fluid Exposures
Drug Metabolism and Disposition·2007· 33 cited
Immediate early gene expression in the visual cortex of normal and dark reared cats: differences between fos and egr-1
Molecular Brain Research·2002· 18 cited
Fibrinogen is an antioxidant that protects β-lipoproteins at physiological concentrations in a cell free system
Atherosclerosis·2001· 37 cited
Immunoelectrophoresis
Encyclopedia of Life Sciences·2001
page 1 of 2Next →

Frequent Co-authors

Richard J. Riese(8), George D. Mower(6), Zhen Luo(5), John Bradley(5), Stanley S. Levinson(5), Jamie Geier(4), K. Soma(3), Andrea Zuckerman(3), Iain B. McInnes(3), Jeffrey R. Curtis(3), M. Boy(3), Yihe Guo(3), Samuel H. Zwillich(3), J Hodge(2), Nathan Wei(2), Sanna Rosengren(2), S. Krishnaswami(2), Christina Charles‐Schoeman(2), Roy Fleischmann(2), Jean Davignon(2)